Close Menu

Takara Bio

This story has been updated from a previous version to include information about the agreement between TATAA Biocenter and Roche.

The headline of this article has been changed from a previous version to clarify Takara Bio Europe's sales strategy.
By Ben Butkus

WaferGen Biosystems said this week that Scott Davidson and Joseph Pesce have joined the company's board of directors.

Eppendorf said this week that it has licensed patents covering gradient technology for thermal cyclers to Takara Bio.

Takara Bio has been awarded US Patent No. 8,048,987, "Polypeptides having DNA polymerase activity."
Yoshimi Sato, Kazue Nishiwaki, Nana Shimada, Shigekazu Hokazono, Takashi Uemori, Hiroyuki Mukai, and Ikunoshin Kato are named as inventors on the patent.

Pages

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.